The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for ...

When a colon tumor grows large enough to completely block the bowel, surgeons have traditionally faced an unenviable choice: ...

A meta-analysis of 41 studies and 3,058 patients shows that detectable circulating tumor DNA after neoadjuvant therapy ...

“Does colorectal cancer surgery mean the anus can’t be preserved?” ... A specialist answers ...

The Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) in combination with chemotherapy on Oct. 8 as an ...

FDA approval is based on results from the landmark Phase III ATOMIC study, published in The New England Journal of Medicine, which showed Tecentriq plus chemotherapy reduced the risk ...

Colorectal cancer most often spreads to the liver. When those liver tumors (called liver metastases) can be removed with ...

Woman survived colon cancer three times after being diagnosed in her teens, 20s and 30s. She shares her symptoms and how ...

This marks a significant new indication for cadonilimab beyond gastric, lung, and cervical cancers, and represents the 13th Phase III/registrational study of the therapy conducted globally.

Tampere University Hospital (Tays) has begun offering a new form of radiotherapy to treat rectal cancer in which a high dose ...

Early-onset colorectal cancer with liver-only metastases can have significant differences in biology from late-onset malignancies.A study of nearly 1,700 individuals from Australia showed early-onset ...

Phase III trial of cadonilimab begins in perioperative colon cancer, testing dual PD-1/CTLA-4 blockade in MSI-H/dMMR patients ...